IOVANCE BIOTHERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase Decrease In Operating Lease Liability of -$2.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$773.00K.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$2.03M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$2.90M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$2.41M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$10.90M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$12.07M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$10.79M.
- IOVANCE BIOTHERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$1.94M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$773.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.80M 10-Q · filed 2026-08-06 | -$5.70M derived: sum of 3 quarters · filed 2026-08-06 | -$8.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.03M 10-Q · filed 2026-05-07 | -$4.93M derived: sum of 2 quarters · filed 2026-05-07 | -$7.34M derived: sum of 3 quarters · filed 2026-05-07 | -$9.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.31M derived: sum of 2 quarters · filed 2026-02-24 | -$7.79M derived: sum of 3 quarters · filed 2026-08-06 | -$10.90M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.89M derived: sum of 2 quarters · filed 2026-08-06 | -$8.00M 10-Q · filed 2025-11-06 | -$11.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.59M 10-Q · filed 2026-08-06 | -$9.24M derived: sum of 3 quarters · filed 2026-08-06 | -$12.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$3.11M 10-Q · filed 2026-05-07 | -$6.76M derived: sum of 2 quarters · filed 2026-05-07 | -$9.71M derived: sum of 3 quarters · filed 2026-05-07 | -$12.40M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$6.60M derived: sum of 2 quarters · filed 2026-02-24 | -$9.29M derived: sum of 3 quarters · filed 2026-02-24 | -$12.07M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.63M derived: sum of 2 quarters · filed 2025-11-06 | -$8.42M 10-Q · filed 2025-11-06 | -$11.14M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.48M 10-Q · filed 2025-08-07 | -$8.20M derived: sum of 3 quarters · filed 2026-02-24 | -$11.01M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$2.79M 10-Q · filed 2025-05-08 | -$5.51M derived: sum of 2 quarters · filed 2026-02-24 | -$8.32M derived: sum of 3 quarters · filed 2026-02-24 | -$11.01M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.53M derived: sum of 2 quarters · filed 2026-02-24 | -$8.22M derived: sum of 3 quarters · filed 2026-02-24 | -$10.79M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$5.50M derived: sum of 2 quarters · filed 2024-11-07 | -$8.07M 10-Q · filed 2024-11-07 | -$10.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$5.26M 10-Q · filed 2024-08-08 | -$7.57M derived: sum of 3 quarters · filed 2025-02-27 | -$8.11M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$2.57M 10-Q · filed 2024-05-09 | -$4.88M derived: sum of 2 quarters · filed 2025-02-27 | -$5.41M derived: sum of 3 quarters · filed 2025-02-27 | -$5.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.84M derived: sum of 2 quarters · filed 2025-02-27 | -$2.63M derived: sum of 3 quarters · filed 2025-02-27 | -$1.94M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$536.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$324.00K derived: sum of 2 quarters · filed 2023-11-07 | $366.00K 10-Q · filed 2023-11-07 | -$127.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $902.00K 10-Q · filed 2023-08-08 | $409.00K derived: sum of 3 quarters · filed 2024-02-28 | -$2.09M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $690.00K 10-Q · filed 2023-05-10 | $197.00K derived: sum of 2 quarters · filed 2024-02-28 | -$2.30M derived: sum of 3 quarters · filed 2024-02-28 | -$3.82M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.99M derived: sum of 2 quarters · filed 2024-02-28 | -$4.51M derived: sum of 3 quarters · filed 2024-02-28 | -$5.88M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$4.01M derived: sum of 2 quarters · filed 2022-11-03 | -$5.39M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.89M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$1.37M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$11.47M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |